Bacterial meningitis caused by gram-negative bacteria

Summary

Bacterial meningitis caused by gram-negative bacteria (MONDO:0041825) is a disease. A subtype of bacterial meningitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	bacterial meningitis caused by gram-negative bacteria
Mondo ID	MONDO:0041825
SNOMED CT	425887005
UMLS	C0854215
MedGen	678524
GARD	0025842
Is cancer (heuristic)	no

Also known as: bacterial meningitis caused by gram-negative bacteria · bacterial meningitis due to gram-negative bacteria · meningitis with gramme negative bacteria

Disease family

This is a subtype of bacterial meningitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › encephalomyelitis › meningitis › infectious meningitis › bacterial meningitis › bacterial meningitis caused by gram-negative bacteria

Related subtypes (7): haemophilus meningitis, streptococcal meningitis, anaerobic meningitis, meningeal tuberculosis, Escherichia coli meningitis, Listeria meningitis, meningococcal meningitis

Subtypes (1): syphilitic meningitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.